AI-generated from publicly available materials.DistillerSR is set to play a pivotal role in the DIGICAP project, aimed at revolutionizing the conformity assessment process for medical devices and in vitro diagnostics across Europe.
The DIGICAP initiative, backed by €4 million in funding from the Horizon Europe program, unites 19 organizations from 12 EU countries to transition from traditional document-based assessments to a more efficient, machine-readable format. DistillerSR, recognized as one of five key technology providers, will collaborate with other industry leaders to develop a digitalization framework that enhances regulatory processes.
As part of its contribution, DistillerSR will engage in co-designing the framework, providing insights into regulatory needs, and participating in pilot testing of new digital tools. This shift to structured electronic submissions is expected to significantly reduce the time and costs associated with conformity assessments, which currently can take up to 24 months. By streamlining these processes, the initiative aims to ensure that new medical technologies are accessible to patients more quickly and safely.
With the DIGICAP project's emphasis on collaboration among notified bodies, manufacturers, and regulatory technology providers, it highlights the growing trend of digital transformation in the healthcare sector. The outcomes of this project could set a new standard for regulatory compliance and patient access in Europe, marking a significant advancement in the medical device landscape.